Cardinal Health stock edges lower ahead of the open
Published on 09/22/2026 at 02:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health stock closed at USD 224.95 on the NYSE on September 18, 2026, down 0.19 percent for the session based on exchange data cited by MarketBeat. The shares traded around that level during the day and remained below a USD 266.56 consensus target referenced in recent market commentary.
September 18, 2026 in numbers
Cardinal Health Inc. (ISIN US14149Y1082, NYSE: CAH) finished the September 18, 2026 session at USD 224.95 after a 0.43 point decline, corresponding to a 0.19 percent loss from the prior close, according to NYSE quote data summarized by MarketBeat and similar portals. An article from ad-hoc-news.de described the same closing level and noted that the stock traded as high as USD 224.95 in the snapshot range cited for that day. A later corporate-news piece on ad-hoc-news.de highlighted that the September 18, 2026 close at USD 224.95 left the shares near their yearly high and about 18.5 percent below a USD 266.56 consensus price target, providing a comparison between the latest close and analyst expectations.
Trading volume for Cardinal Health on September 18, 2026 was consistent with recent averages per NYSE data summaries on portals such as MarketBeat, and the intraday range kept the close within the current 52 week band cited in that coverage. With the stock essentially flat to slightly lower on the day, it underperformed the broader US equity benchmarks that have recently been supported by gains in health care and related sectors, as suggested by index commentary such as reports on the Nifty Pharma index from Business Standard, even though those figures relate to a different regional market and serve primarily as sector context.
Outlook today and upcoming earnings
Looking ahead to today, September 22, 2026, investors remain focused on Cardinal Health’s next quarterly results and related guidance even though those figures are not due immediately. As Zacks reported on September 21, 2026, Cardinal Health is scheduled to report earnings on October 29, 2026, with a Most Accurate Estimate of USD 2.96 per share versus a Zacks Consensus Estimate of USD 2.92, and an Earnings ESP of +1.29 percent, figures that frame expectations for the forthcoming release. Broader sentiment toward the stock is also shaped by recent analyst work on price targets and executive compensation trends, including coverage on Quiver Quantitative that compiles recent analyst targets with a median around USD 245.00, adding another numerical reference point to the gap between the latest close and prevailing estimates. With no major company specific release confirmed for September 22, 2026 itself, attention today centers on how Cardinal Health stock trades ahead of that October earnings date against the backdrop of broader health care and medical distribution trends in the US equity market.
